These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34310262)

  • 1. Plasma IL-6 levels in unmedicated, comorbidity free obsessive-compulsive disorder.
    Jose D; Dinakaran D; Shivakumar V; Subbanna M; Reddy YCJ; Venkatasubramanian G; Narayanaswamy JC
    Int J Psychiatry Clin Pract; 2021 Nov; 25(4):437-440. PubMed ID: 34310262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cytokine abnormalities in drug-naïve, comorbidity-free obsessive-compulsive disorder.
    Rao NP; Venkatasubramanian G; Ravi V; Kalmady S; Cherian A; Yc JR
    Psychiatry Res; 2015 Oct; 229(3):949-52. PubMed ID: 26187339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder.
    Karagüzel EÖ; Arslan FC; Uysal EK; Demir S; Aykut DS; Tat M; Karahan SC
    Compr Psychiatry; 2019 Feb; 89():61-66. PubMed ID: 30594753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder.
    Konuk N; Tekin IO; Ozturk U; Atik L; Atasoy N; Bektas S; Erdogan A
    Mediators Inflamm; 2007; 2007():65704. PubMed ID: 17497035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe symptoms predict salivary interleukin-6, interleukin-1β, and tumor necrosis factor-α levels in children and youth with obsessive-compulsive disorder.
    Westwell-Roper C; Best JR; Naqqash Z; Au A; Lin B; Lu C; Shao L; Beasley CL; Stewart SE
    J Psychosom Res; 2022 Apr; 155():110743. PubMed ID: 35190349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disgust affects TNF-alpha, IL-6 and noradrenalin levels in patients with obsessive-compulsive disorder.
    Fluitman SB; Denys DA; Heijnen CJ; Westenberg HG
    Psychoneuroendocrinology; 2010 Jul; 35(6):906-11. PubMed ID: 20044210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidity, age of onset and suicidality in obsessive-compulsive disorder (OCD): An international collaboration.
    Brakoulias V; Starcevic V; Belloch A; Brown C; Ferrao YA; Fontenelle LF; Lochner C; Marazziti D; Matsunaga H; Miguel EC; Reddy YCJ; do Rosario MC; Shavitt RG; Shyam Sundar A; Stein DJ; Torres AR; Viswasam K
    Compr Psychiatry; 2017 Jul; 76():79-86. PubMed ID: 28433854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher prevalence of irritable bowel syndrome and greater gastrointestinal symptoms in obsessive-compulsive disorder.
    Turna J; Grosman Kaplan K; Patterson B; Bercik P; Anglin R; Soreni N; Van Ameringen M
    J Psychiatr Res; 2019 Nov; 118():1-6. PubMed ID: 31437616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates.
    Lochner C; Hemmings SM; Kinnear CJ; Niehaus DJ; Nel DG; Corfield VA; Moolman-Smook JC; Seedat S; Stein DJ
    Compr Psychiatry; 2005; 46(1):14-9. PubMed ID: 15714189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of proinflammatory cytokines in obsessive-compulsive disorder.
    Gray SM; Bloch MH
    Curr Psychiatry Rep; 2012 Jun; 14(3):220-8. PubMed ID: 22477442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of comorbid obsessive-compulsive disorder in patients with bipolar disorder: The clinic-based prevalence rate, symptoms nature and clinical correlates.
    Jeon S; Baek JH; Yang SY; Choi Y; Ahn SW; Ha K; Hong KS
    J Affect Disord; 2018 Jan; 225():227-233. PubMed ID: 28841485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overlapping features between social anxiety and obsessive-compulsive spectrum in a clinical sample and in healthy controls: toward an integrative model.
    Carpita B; Muti D; Petrucci A; Romeo F; Gesi C; Marazziti D; Carmassi C; Dell'Osso L
    CNS Spectr; 2020 Aug; 25(4):527-534. PubMed ID: 31576793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of obsessive-compulsive disorder comorbidity and obsessive-compulsive symptom dimensions in patients with schizophrenia.
    Kokurcan A; Şafak Y
    Saudi Med J; 2020 Mar; 41(3):275-282. PubMed ID: 32114600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe obsessive-compulsive disorder with and without comorbid hair pulling: comparisons and clinical implications.
    Stewart SE; Jenike MA; Keuthen NJ
    J Clin Psychiatry; 2005 Jul; 66(7):864-9. PubMed ID: 16013902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compulsive sexual behavior disorder in obsessive-compulsive disorder: Prevalence and associated comorbidity.
    Fuss J; Briken P; Stein DJ; Lochner C
    J Behav Addict; 2019 Jun; 8(2):242-248. PubMed ID: 31079471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features associated with increased severity of illness in tertiary clinic referred patients with obsessive compulsive disorder.
    Dell'Osso B; Benatti B; Hollander E; Altamura AC
    Int J Psychiatry Clin Pract; 2017 Jun; 21(2):131-136. PubMed ID: 27809644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations.
    Maes M; Meltzer HY; Bosmans E
    Neuropsychobiology; 1994; 30(2-3):57-60. PubMed ID: 7800164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced T cell immunity in unmedicated, comorbidity-free obsessive-compulsive disorder: An immunophenotyping study.
    Subbanna M; Shivakumar V; Jose D; Venkataswamy M; Debnath M; Ravi V; Reddy YCJ; Venkatasubramanian G; Narayanaswamy JC
    J Psychiatr Res; 2021 May; 137():521-524. PubMed ID: 33813311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased thalamic glutamate level in unmedicated adult obsessive-compulsive disorder patients detected by proton magnetic resonance spectroscopy.
    Zhu Y; Fan Q; Han X; Zhang H; Chen J; Wang Z; Zhang Z; Tan L; Xiao Z; Tong S; Maletic-Savatic M; Li Y
    J Affect Disord; 2015 Jun; 178():193-200. PubMed ID: 25819113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-Related Comorbidities in Childhood-Onset Obsessive Compulsive Disorder: Lifetime Prevalence in the Obsessive Compulsive Disorder Collaborative Genetics Association Study.
    Westwell-Roper C; Williams KA; Samuels J; Bienvenu OJ; Cullen B; Goes FS; Grados MA; Geller D; Greenberg BD; Knowles JA; Krasnow J; McLaughlin NC; Nestadt P; Shugart YY; Nestadt G; Stewart SE
    J Child Adolesc Psychopharmacol; 2019 Oct; 29(8):615-624. PubMed ID: 31170001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.